DMT1 (NRAMP2/DCT1) Genetic Variability and Resistance to Recombinant Human Erythropoietin Therapy in Chronic Kidney Disease Patients under Haemodialysis
暂无分享,去创建一个
L. Belo | A. Santos-Silva | A. Quintanilha | F. Reis | S. Rocha | E. Costa | P. Rocha-Pereira | F. Teixeira | V. Miranda | A. Loureiro | M. do Sameiro Faria | E. Castro | Elisabeth Castro
[1] B. Pereira,et al. Role of Prohepcidin, Inflammatory Markers and Iron Status in Resistance to rhEPO Therapy in Hemodialysis Patients , 2008, American Journal of Nephrology.
[2] V. Subramaniam,et al. Non-HFE haemochromatosis. , 2007, World journal of gastroenterology.
[3] P. Messa,et al. HFE Genotype Influences Erythropoiesis Support Requirement in Hemodialysis Patients: A Prospective Study , 2007, American Journal of Nephrology.
[4] Laurent Excoffier,et al. Arlequin (version 3.0): An integrated software package for population genetics data analysis , 2005, Evolutionary bioinformatics online.
[5] W. Hörl,et al. New insights into the regulation of iron homeostasis , 2006, European journal of clinical investigation.
[6] J. Crowe,et al. DMT1 genetic variability is not responsible for phenotype variability in hereditary hemochromatosis. , 2004, Blood cells, molecules & diseases.
[7] T. Ikizler,et al. Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. , 2004, Kidney international.
[8] F. Locatelli,et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] N. Levin,et al. Oxidative stress and inflammation in hemodialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] N. Andrews,et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene , 1997, Nature genetics.